93 related articles for article (PubMed ID: 2864788)
1. [Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients].
Marchant N; Caruso S; Cuervo L; Brizuela A
Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):37-41. PubMed ID: 2864788
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficacy of haloperidol decanoate].
Alvarez JV; Li Gambi M
Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with bromperidol in chronic psychoses].
Bellomo LE; Rosset N; Tellarini L; Forconesi N
Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
5. Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate.
Youssef HA
Clin Neuropharmacol; 1991; 14 Suppl 2():S16-21; discussion S22-3. PubMed ID: 1684308
[TBL] [Abstract][Full Text] [Related]
6. [Open clinical trial with haloperidol decanoate in patients with psychotic disorders].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1987 Jun; 33(2):157-62. PubMed ID: 3321918
[TBL] [Abstract][Full Text] [Related]
7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
8. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
[TBL] [Abstract][Full Text] [Related]
10. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
[TBL] [Abstract][Full Text] [Related]
11. Preliminary note on the antipsychotic efficacy of bromperidol.
Bataille M
Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
De Cuyper H; Bollen J; van Praag HM; Verstraeten D
Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
[TBL] [Abstract][Full Text] [Related]
13. Use of haloperidol decanoate in psychiatric diseases.
Zonda T; Kövári E
Ther Hung; 1992; 40(2):64-8. PubMed ID: 1361081
[TBL] [Abstract][Full Text] [Related]
14. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].
Levi Minzi A; Laviani M
Minerva Psichiatr; 1992; 33(1):51-5. PubMed ID: 1406161
[TBL] [Abstract][Full Text] [Related]
16. [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
Youssef HA
Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):297-304. PubMed ID: 6152573
[No Abstract] [Full Text] [Related]
17. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
18. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
19. Utilization of depot neuroleptic medication in psychiatric inpatients.
Citrome L; Levine J; Allingham B
Psychopharmacol Bull; 1996; 32(3):321-6. PubMed ID: 8961774
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.
Beresford R; Ward A
Drugs; 1987 Jan; 33(1):31-49. PubMed ID: 3545764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
